| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |